Clinical Trial Update: A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports the completion of a single- and multiple-dose study assessing the safety of JNJ-38224342 in healthy volunteers and patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• JNJ-38224342

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Seasonal Allergic Rhinitis | Phase 1 | Status: COMPLETED